T-cell therapy
-
Kite Pharma to launch in the fourth quarter of this year a Phase 2 trial of T-cell therapy in leukemia patients
Jun 5, 2017News Hour: Kite Pharma Inc said on Monday it planned to launch in the fourth quarter of this year a Phase 2 trial of its experimental T-cell therapy in leukemia patients, possibly at a lower dose...
